Cardinal Health (CAH) Loses Bid to Halt DEA Suspension of Drug Shipment in Florida
Tweet
Share
E-mailGet Alerts CAH Hot Sheet
Price: $108.19 +2.07%
Overall Analyst Rating:
NEUTRAL (
Up)
Dividend Yield: 1.8%
EPS Growth %: +12.6%
Overall Analyst Rating:
NEUTRAL (
Up)Dividend Yield: 1.8%
EPS Growth %: +12.6%
Join SI Premium – FREE
Shares of Cardinal Health (NYSE: CAH) dipped in mid-day trade Friday afternoon, however, the stock has mostly already erased a chunk of the loss. The move follows headlines from Bloomberg which suggest the company lost a bid to halt the DEA's suspension of a drug shipment in Florida.
The stock is down 0.17 percent to $41.63 at last check.
The stock is down 0.17 percent to $41.63 at last check.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Mondi Says It Does Not Intend To Make An Offer For DS Smith
- Odyssey Marine Exploration (OMEX) Receives Nasdaq Non-compliance Notice
- Tandy Leather Factory (TLF) Appoints Diana Saadeh-Jajeh to its Board
Create E-mail Alert Related Categories
Corporate News, RumorsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
